Distinct Patterns of Cytokine and Angiogenic Factor Modulation and Markers of Benefit for Vandetanib and/or Chemotherapy in Patients With Non–Small-Cell Lung Cancer

PURPOSE: There is an unmet need for biomarkers for identifying patients likely to benefit from anticancer treatments, selecting dose, and understanding mechanisms of resistance. Plasma vascular endothelial growth factor (VEGF) and soluble VEGF receptor 2 (sVEGFR-2) are known to be modulated by VEGF...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hanrahan, Emer O., Lin, Heather Y., Kim, Edward S., Yan, Shaoyu, Du, Danny Z., McKee, Kathryn S., Tran, Hai T., Lee, J. Jack, Ryan, Anderson J., Langmuir, Peter, Johnson, Bruce E., Heymach, John V.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3040010/
https://ncbi.nlm.nih.gov/pubmed/19949019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.22.4279
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados